Using cell-free DNA
to profile the tumor microenvironment
to profile the tumor microenvironment
LiquidCell Dx is building the first truly comprehensive cancer ecosystem profiling platform — from a simple blood draw
LiquidCell Dx provides a complete picture of the tumor and its microenvironment in a cost-effective and scalable liquid biopsy. By measuring what existing diagnostics miss — the tumor microenvironment — we predict therapy response with unprecedented accuracy.
Cancer is a spatial ecosystem, not just a tumor
Today's tumor profiling tools focus narrowly on the tumor itself — mutations, genomic profiles, individual biomarkers. But molecularly similar tumors behave very differently, and the reason lies outside the tumor cell.
Existing tools to profile this spatial ecosystem require invasive tissue biopsies or lack the resolution to capture its complexity. LiquidCell Dx looks at the whole cancer spatial ecosystem — not just the tumor — from a simple blood draw.
Same seed, restrictive ecosystem
limited growth
Same seed, permissive ecosystem
aggressive spread
Tumor microenvironmentThe surrounding network of immune cells, stromal cells, vasculature, and signaling — shapes whether a therapy will work. It can block or enable treatment response across immunotherapy, ADCs, and targeted therapies.
From blood sample to biological insight
Proprietary integrated AI platform that decodes spatial ecosystem biology to guide treatment decisions and drug development.
Blood Draw
A non-invasive liquid biopsy captures signals from both the tumor and its surrounding microenvironment.
AI Platform
Our Detection AI maps signals to nine biologically interpretable states. Signals reflect hallmark features of the tumor microenvironment.
High-resolution profiling of the tumor microenvironment with spatial ecotypes
Read PaperClinical Output
Patient samples are classified into Spatial Ecotypes and translated into a clear, clinically relevant report.
Science & Updates
Built by Leaders in Genomics, Oncology and AI
We are physician-scientists, computational biologists, and biotech operators with deep expertise across spatial transcriptomics, cell-free DNA biology, and cancer profiling and monitoring. Our founding science introduced the spatial ecotype framework and the methods that make it readable from blood. Together, we built LiquidCell Dx to bring spatial tumor microenvironment profiling and monitoring out of the research lab and into routine clinical practice.
Partner With Us
We're building the future of cancer diagnostics with clinical, pharmaceutical, and diagnostic partners.
Pharmaceutical
Clinical trial collaborations and companion diagnostic development
Clinical
Academic and clinical validation studies across tumor types
Profiling and Monitoring
Integration with existing genomic profiling workflows and laboratory infrastructure